Craig Johnson

Craig Johnson is recorded as Board Member at Aurinia Pharmaceuticals Inc. (AUPH) and Board Member at Heron Therapeutics, Inc. (HRTX) since January 1, 2014. The newest filing on record that lists Craig Johnson as Board Member at Aurinia Pharmaceuticals Inc. (AUPH) is dated April 21, 2026. The newest filing on record that lists Craig Johnson as Board Member at Heron Therapeutics, Inc. (HRTX) is dated April 30, 2026. Aurinia Pharmaceuticals Inc. reported in an 8-K filed March 23, 2026 that Craig Johnson was appointed Lead Independent Director, effective March 21, 2026. Aurinia Pharmaceuticals Inc. reported in an 8-K filed May 15, 2025 that Craig Johnson was appointed members of the Company's board of directors, effective May 15, 2025. Aurinia Pharmaceuticals Inc. reported in an 8-K filed November 7, 2024 that Craig Johnson was appointed Board of Directors, effective November 7, 2024. Equibles holds 4 filed executive changes naming Craig Johnson; each is listed under recent activity with its source filing. Aurinia Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Heron Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aurinia Pharmaceuticals Inc. includes Jeffrey Bailey (CEO and Board Member), Kevin Tang (CEO and Board Member), Peter Greenleaf (CEO and Board Member) and 7 others.